Meprobamate

Chemical formula: C₉H₁₈N₂O₄  Molecular mass: 218.25 g/mol  PubChem compound: 4064

Therapeutic indications

Meprobamate is indicated for:

Anxiety

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Meprobamate is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually do not require treatment with an anxiolytic.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Meprobamate is contraindicated in the following cases:

Acute intermittent porphyria

Acute intermittent porphyria

Allergic or idiosyncratic reactions to meprobamate, carisoprodol, mebutamate, tybamate, carbromal

at least one of
Meprobamate allergy
Meprobamate adverse reaction
Carbamate sedative adverse reaction
Carisoprodol adverse reaction
Adverse reaction to carbromal

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL) 2023: MEPROBAMATE Tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈